Post-diagnostic support program for people with dementia and carers
- Conditions
- dementiaNeurological - Dementias
- Registration Number
- ACTRN12622001522707
- Lead Sponsor
- niversity of Canberra
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 24
Eligible participants will be people with dementia (all forms) and their carer (as nominated by the person with dementia). Participants will be living independently in the community and will be recruited from within the ACT. People with dementia will be required to participate with a carer. The carer may be male or female, must be aged over 18 years, and providing ongoing support to the person with dementia. Potential participants will be screened using the Clinical Dementia Rating scale (CDR). Participants with mild to moderate scores of between 0.5 and 2 will be eligible to participate. Participants need to be willing to attend for greater than 10 weeks (i,e. do not have a holiday planned).
People with dementia may be excluded if they are unable to engage in, or requires 1:1 support for group participation due to disruptive behaviours and/or wandering behaviour, or severely impaired hearing or vision. Participants with a CDR score of 0 and 3 will be excluded. People with dementia who do not have a carer or support person willing to participate in required program components will be excluded.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Quality of life. The primary outcome will be change in the DEMQOL (Dementia Health-related Quality of Life). The 28-item questionnaire is designed for people with dementia (DEMQOL) (Smith, Lamping et al. 2005). The DEMQOL is a self-reported, interviewer-assessed questionnaire that inquires about the person with dementia’s feelings, memory, and everyday life activities from the last week. [Intervention group: <br>T1 = Baseline/Pre-intervention<br>T2 = Post-intervention at week 12 <br>T3 = Follow-up at week 24 (Primary endpoint)<br><br>Waiting-list group:<br>T0 = Baseline<br>T1 = Pre-intervention at week 12 <br>T2 = Post-intervention at week 24<br>T3 = Follow-up at week 36 (Primary endpoint)]
- Secondary Outcome Measures
Name Time Method